Comparison of SP TFL and Ho:YAG for RIRS Using 145 µm and 200 µm Fibers

NCT ID: NCT04346485

Last Updated: 2021-07-22

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

105 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-03-13

Study Completion Date

2022-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The authors hypothesize that the RIRS using 150-microm Tm-fiber laser is superior than fiber with larger diameters, as 200-microm Tm-fiber laser or 200-microm holmium fiber laser, in such points as follows:

* decreasing surgery time and laser-on time due to possibility of 4.3 fold ablation efficacy increase, which has been shown by Andreeva et al.;
* increasing the flexible ureteroscope tip deflection lower pole stones availability;
* decreased risk of complications and a better irrigation and visualization due to better irrigation with smaller fiber;
* increasing of lithotripsy efficacy and laser beam density by lowering of beam focal spot due to using of lesser fiber diameter

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

RIRS will be performed with SP TFL or Ho:YAG (100 W). The procedure is performed under general anesthesia with the patient in the dorsal lithotomy position. The bladder is entered either with a cystoscope or a semi-rigid ureterorenoscope. Guidewires (0.035") will be used to facilitate access (under fluoroscopic guidance). After access sheath (12/14) will be placed up to the kidney pelvis. Through the access sheath ureteroscope will be introduced. For nephrolithotripsy 145 mcm and 200 mcm fibers will be used. Large fragments could be extracted with nitinol basket. After the surgery ureteral stent (7 Fr.) will be placed inside the ureter for 10 to 14 days.

A 10 Fr urethral catheter can be placed in the bladder for the drainage of the bladder during the operation.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Kidney Stone Nephrolithiasis Urolithiasis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

SP TFL RIRS with 145 mcm fiber

Superpulse thulium fiber laser RIRS with 145 mcm laser fiber

Group Type EXPERIMENTAL

SP TFL RIRS with 145 mcm fiber

Intervention Type PROCEDURE

retrograde intrarenal surgery

SP TFL RIRS with 200 mcm fiber

Superpulse thulium fiber laser RIRS with 200 mcm laser fiber

Group Type EXPERIMENTAL

SP TFL RIRS with 200 mcm fiber

Intervention Type PROCEDURE

retrograde intrarenal surgery

Ho:YAG RIRS with 200 mcm fiber

Ho:YAG laser RIRS with 200 mcm laser fiber

Group Type ACTIVE_COMPARATOR

Ho:YAG RIRS with 200 mcm fiber

Intervention Type PROCEDURE

retrograde intrarenal surgery

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

SP TFL RIRS with 145 mcm fiber

retrograde intrarenal surgery

Intervention Type PROCEDURE

SP TFL RIRS with 200 mcm fiber

retrograde intrarenal surgery

Intervention Type PROCEDURE

Ho:YAG RIRS with 200 mcm fiber

retrograde intrarenal surgery

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Males and Females \> 18 y.o.;
* Radiologically confirmed (CT) kidney stone;
* Stone size from 10 to 20 mm.

Exclusion Criteria

• Multiple (more than 3) kidney stones \> 5 mm
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

I.M. Sechenov First Moscow State Medical University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Dmitry Enikeev, MD, PhD

Deputy director for research

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Institute for Urology and Reproductive Health, Sechenov University.

Moscow, , Russia

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Russia

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Dmitry Enikeev, MD

Role: primary

+7 925 517 79 26

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Sechenov-RIRS-20

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

HoYAG vs TFL in miniPCNL With ClearPetra
NCT07087977 NOT_YET_RECRUITING NA